NPP 150

NPP 150 Dragon Pharma — Overview

NPP 150 Dragon Pharma is nandrolone phenylpropionate at 150 mg/ml — the short-ester form of nandrolone, one of the most widely used anabolic compounds in performance protocols. Where Deca 300 (nandrolone decanoate) requires once- or twice-weekly injections and a 3-week clearance window before PCT, NPP runs on a 4–5 day half-life that produces faster onset, tighter blood level control, and the ability to start PCT approximately one week after the last injection. The active compound is identical: 19-nortestosterone, a modified testosterone molecule lacking the C-19 methyl group, which substantially reduces androgenic potency while preserving and amplifying anabolic activity.

NPP is valued for three practical properties that distinguish it from most other injectable AAS: exceptionally high nitrogen retention that creates a pronounced anti-catabolic environment, documented stimulation of collagen synthesis that provides genuine joint and tendon relief during heavy training, and a lean tissue profile that produces quality muscle with less water retention than high-dose testosterone. Available at Steroid Warehouse as a 150 mg/ml oil solution, NPP fits both dedicated mass cycles and recomposition protocols at moderate to intermediate doses. The non-negotiable rule for nandrolone use — always co-administer testosterone — is covered fully in the Who It's For section.

About the Compound: Nandrolone Phenylpropionate

Nandrolone is a 19-nortestosterone derivative — structurally identical to testosterone except for the absence of the C-19 methyl group. This single modification has significant downstream consequences: the compound binds androgen receptors with high affinity but undergoes 5α-reductase conversion to dihydronandrolone (DHN) rather than the potent DHT. DHN is a dramatically weaker androgen, which explains nandrolone's low androgenic rating (37 vs testosterone's 100). The same modification also confers progestogenic activity: nandrolone binds progesterone receptors with meaningful affinity, which is relevant for understanding its gynecomastia profile and the phenomenon commonly called "deca dick."

The phenylpropionate ester determines the pharmacokinetic profile. The PP ester produces a half-life of approximately 4–5 days, requiring injection every other day (EOD) or every 3 days (E3D) for stable blood levels. At 150 mg/ml, each millilitre delivers exactly 150 mg of nandrolone phenylpropionate. A typical working dose of 300–400 mg/week therefore requires 2–3 ml distributed across 3–4 injections per week. Nandrolone aromatizes to estradiol at roughly 20% of testosterone's rate — meaningful but moderate. IGF-1 stimulation is documented: nandrolone increases local and systemic IGF-1 production, contributing to its muscle-building and connective tissue effects beyond direct androgen receptor activation alone.

What NPP Does

• Lean muscle accumulation with high nitrogen retention — nandrolone's nitrogen retention effect is among the strongest of any AAS; a highly positive nitrogen balance means the body is consistently in an anabolic state regardless of caloric intake; this translates to sustained muscle accrual during a bulk and effective muscle preservation during a caloric deficit; at 300–400 mg/week, body composition changes are lean and progressive, with less water retention than equivalent testosterone doses because aromatization is lower and estradiol accumulation is more moderate
• Collagen synthesis and joint relief — nandrolone stimulates type I and III collagen production in connective tissue; this is not a masking effect but a genuine structural benefit: tendons and ligaments become thicker and more resilient, and users with chronic joint issues (shoulders, knees, elbows) consistently report reduced pain and improved joint function during NPP cycles; this property makes NPP a practical addition to cycles involving heavy compound lifts, and it benefits users who have pushed joint health to its limits in previous training blocks
• IGF-1 stimulation and anabolic environment — nandrolone increases both circulating and local IGF-1 production; IGF-1 acts synergistically with androgen receptor activation to promote satellite cell recruitment, muscle protein synthesis, and recovery; the combined direct AR binding + IGF-1 elevation creates a potent anabolic environment at moderate doses that would require significantly higher testosterone doses to replicate via testosterone alone
• Red blood cell production — like other AAS, nandrolone stimulates erythropoiesis via EPO pathway upregulation; increased red blood cell count and haematocrit improve oxygen delivery to muscle, contributing to training endurance and recovery; this effect is real but moderate compared to compounds like Boldenone (EQ) which has stronger erythropoietic activity
• Appetite and recovery — users consistently report improved appetite and faster recovery between sessions, particularly when NPP is dosed at or above 300 mg/week; this is partly mediated by the anabolic environment (reduced muscle damage, faster protein turnover) and partly by the general well-being associated with androgen-elevated states

Who It's For

• Intermediate and experienced AAS users in bulking or recomposition phases — NPP is not an appropriate first cycle compound; it requires an understanding of how to manage estrogen and prolactin, and its mandate for testosterone co-administration adds complexity that beginners should not navigate simultaneously with learning baseline AAS management; for users with at least one testosterone-only cycle completed, NPP at 300–400 mg/week alongside Enantat 250 at 300–400 mg/week is the classic lean bulk stack; it delivers lean mass accumulation with joint support throughout and is manageable in terms of side effect profile
• Users with joint or tendon issues who want to train heavy — the collagen synthesis benefit is arguably NPP's most practically valuable property beyond mass building; users recovering from shoulder or knee injuries, or those who experience joint pain during heavy squats, deadlifts, or pressing, often find NPP at even modest doses (200–300 mg/week) significantly reduces pain and improves joint tolerance; this makes NPP useful as an addition to any testosterone-based cycle where joint health is a limiting factor
• Users preferring shorter-ester nandrolone over Deca — anyone who has run Deca and experienced side effects appreciates NPP's faster clearance; if prolactin climbs or libido suffers, reducing NPP dose has a measurable effect within days rather than weeks; PCT timing is also dramatically better (7 days vs 3 weeks), meaning testosterone recovery begins sooner; for shorter cycles of 10–12 weeks, NPP simply makes more pharmacological sense than Deca
• Users who should choose something else: those with a history of prolactin-related sexual dysfunction or known progestin sensitivity should approach nandrolone with caution regardless of ester; if the primary goal is cutting, hardening, or eliminating water retention rather than building mass and supporting joints, Masteron or Primobolan are more appropriate; users unwilling or unable to inject every other day or every 3 days should consider Deca instead

Mandatory rule for nandrolone use: nandrolone must always be co-administered with testosterone. Nandrolone suppresses endogenous testosterone production strongly; without exogenous testosterone to maintain adequate androgen levels, the conversion of nandrolone to the weak DHN (rather than DHT) leaves penile tissue and CNS androgenic receptors under-stimulated relative to nandrolone's progestogenic activity — the mechanism behind "deca dick" (libido suppression and erectile dysfunction). A minimum testosterone dose of 200 mg/week (TRT equivalent) is required; most protocols use a 1:1 or 2:1 testosterone:NPP ratio to maintain sexual function throughout the cycle.

NPP vs Alternatives

Combinations

Side Effects & Management

Bloodwork Monitoring

PCT

Because the phenylpropionate ester clears in approximately 4–5 days (versus ~15 days for decanoate), PCT can begin approximately 7 days after the last NPP injection. If the cycle also included a long-ester testosterone (e.g., Enantat 250), PCT timing is determined by the testosterone ester: begin PCT 2 weeks after the last testosterone enanthate or cypionate injection, not by the NPP clearance timeline.

Practical Summary

References